1887

Abstract

The Nef protein is a crucial pathogenicity factor of human immunodeficiency virus type 1 (HIV-1) that contains a proline-rich motif consisting of four conserved prolines: Pro69 (P69), P72, P75 and P78. P72 and P75 were shown to bind Src homology domains 3 (SH3) and have been implicated in many biological functions of Nef, including downmodulation of cell-surface major histocompatibility complex class I (MHC-I). P78 is involved together with P69 in positioning of the Nef–SH3 complex and it has been shown to be essential for Nef activity of MHC-I downmodulation. It is shown here that alteration of P78 affects recycling of MHC-I molecules to the cell surface, but does not interfere with SH3 binding. In addition, it is demonstrated that P72 and P75, and thus the SH3-binding capacity, are fully dispensable for Nef activity on MHC-I.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81775-0
2006-08-01
2020-10-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/8/2291.html?itemId=/content/journal/jgv/10.1099/vir.0.81775-0&mimeType=html&fmt=ahah

References

  1. Arold S. T., Baur A. S. 2001; Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 26:356–363 [CrossRef]
    [Google Scholar]
  2. Arold S., Franken P., Strub M. P., Hoh F., Benichou S., Benarous R., Dumas C. 1997; The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5:1361–1372 [CrossRef]
    [Google Scholar]
  3. Blagoveshchenskaya A. D., Thomas L., Feliciangeli S. F., Hung C.-H., Thomas G. 2002; HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111:853–866 [CrossRef]
    [Google Scholar]
  4. Casartelli N., Di Matteo G., Argentini C. & 7 other authors 2003a; Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. AIDS 17:1291–1301 [CrossRef]
    [Google Scholar]
  5. Casartelli N., Di Matteo G., Potestà M., Rossi P., Doria M. 2003b; CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 Nef protein in pediatric AIDS progression. J Virol 77:11536–11545 [CrossRef]
    [Google Scholar]
  6. Chang A. H., O'Shaughnessy M. V., Jirik F. R. 2001; Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation. Eur J Immunol 31:2382–2387 [CrossRef]
    [Google Scholar]
  7. Craig H. M., Pandori M. W., Riggs N. L., Richman D. D., Guatelli J. C. 1999; Analysis of the SH3-binding region of HIV-1 Nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket. Virology 262:55–63 [CrossRef]
    [Google Scholar]
  8. Deacon N. J., Tsykin A., Solomon A. & 17 other authors 1995; Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988–991 [CrossRef]
    [Google Scholar]
  9. Fackler O. T., Baur A. S. 2002; Live and let die: Nef functions beyond HIV replication. Immunity 16:493–497 [CrossRef]
    [Google Scholar]
  10. Fackler O. T., Kienzle N., Kremmer E., Boese A., Schramm B., Klimkait T., Kucherer C., Mueller-Lantzsch N. 1997; Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur J Biochem 247:843–851 [CrossRef]
    [Google Scholar]
  11. Fackler O. T., Luo W., Geyer M., Alberts A. S., Peterlin B. M. 1999; Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol Cell 3:729–739 [CrossRef]
    [Google Scholar]
  12. Federico M. 2004; Targeting the Nef induced increase of HIV infectivity. Curr Drug Targets Immune Endocr Metabol Disord 4:321–326 [CrossRef]
    [Google Scholar]
  13. Geyer M., Fackler O. T., Peterlin B. M. 2001; Structure–function relationships in HIV-1 Nef. EMBO Rep 2:580–585 [CrossRef]
    [Google Scholar]
  14. Greenberg M. E., Iafrate A. J., Skowronski J. 1998; The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 17:2777–2789 [CrossRef]
    [Google Scholar]
  15. Hanna Z., Kay D. G., Rebai N., Guimond A., Jothy S., Jolicoeur P. 1998; Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95:163–175 [CrossRef]
    [Google Scholar]
  16. Hanna Z., Weng X., Kay D. G., Poudrier J., Lowell C., Jolicoeur P. 2001; The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 75:9378–9392 [CrossRef]
    [Google Scholar]
  17. Iafrate A. J., Bronson S., Skowronski J. 1997; Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J 16:673–684 [CrossRef]
    [Google Scholar]
  18. Kasper M. R., Collins K. L. 2003; Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J Virol 77:3041–3049 [CrossRef]
    [Google Scholar]
  19. Kawano Y., Tanaka Y., Misawa N. & 10 other authors 1997; Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo. J Virol 71:8456–8466
    [Google Scholar]
  20. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. 1995; Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228–232 [CrossRef]
    [Google Scholar]
  21. Krautkrämer E., Giese S. I., Gasteier J. E., Muranyi W., Fackler O. T. 2004; Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J Virol 78:4085–4097 [CrossRef]
    [Google Scholar]
  22. Larsen J. E., Massol R. H., Nieland T. J. F., Kirchhausen T. 2004; HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity. Mol Biol Cell 15:323–331
    [Google Scholar]
  23. Lee C.-H., Leung B., Lemmon M. A., Zheng J., Cowburn D., Kuriyan J., Saksela K. 1995; A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 14:5006–5015
    [Google Scholar]
  24. Lee C.-H., Saksela K., Mirza U. A., Chait B. T., Kuriyan J. 1996; Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85:931–942 [CrossRef]
    [Google Scholar]
  25. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J.-M., Schwartz O. 1998; Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8:483–495 [CrossRef]
    [Google Scholar]
  26. Liu X., Schrager J. A., Lange G. D., Marsh J. W. 2001; HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations. J Biol Chem 276:32763–32770 [CrossRef]
    [Google Scholar]
  27. Mangasarian A., Piguet V., Wang J.-K., Chen Y.-L., Trono D. 1999; Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 73:1964–1973
    [Google Scholar]
  28. Manninen A., Hiipakka M., Vihinen M., Lu W., Mayer B. J., Saksela K. 1998; SH3-domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 250:273–282 [CrossRef]
    [Google Scholar]
  29. Peterlin B. M., Trono D. 2003; Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 3:97–107 [CrossRef]
    [Google Scholar]
  30. Riggs N. L., Craig H. M., Pandori M. W., Guatelli J. C. 1999; The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. Virology 258:203–207 [CrossRef]
    [Google Scholar]
  31. Roeth J. F., Williams M., Kasper M. R., Filzen T. M., Collins K. L. 2004; HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J Cell Biol 167:903–913 [CrossRef]
    [Google Scholar]
  32. Saksela K., Cheng G., Baltimore D. 1995; Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14:484–491
    [Google Scholar]
  33. Yamada T., Kaji N., Odawara T., Chiba J., Iwamoto A., Kitamura Y. 2003; Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J Virol 77:1589–1594 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81775-0
Loading
/content/journal/jgv/10.1099/vir.0.81775-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error